Cbd Unlimited Balmx Topical Analgesic
Product Images NDC 73045-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cbd Unlimited Balmx Topical Analgesic (NDC 73045-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endexx Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label-1 (Label 1)

Label for CBD UNLIMITED BALMX Topical Analgesic, 2 oz (60 mL) tube, containing 1000 mg premium hemp isolate. The product is marketed as a topical analgesic with menthol USP 1.25%, intended for external use only. The label highlights hemp industry leadership since 2014, controlled production process, and scientific formulation. Distributed by CBD Unlimited, Inc., Cave Creek, Arizona, USA.*

FDA Label Image

Label-2 (Label 2)

Label for CBD UNLIMITED BALMX Topical Analgesic, 2 oz (60 mL) tube. The label indicates it is for external use only and contains menthol USP 1.25% as the active ingredient and 1000 mg hemp isolate. The product is U.S. grown hemp, manufactured in America by CBD Unlimited Inc., Cave Creek, AZ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.